She has also been appointed associate chief in the division of hematology/oncology at Boston Children’s Hospital, according to a Feb. 19 news release from the cancer institute.
Dr. Stegmaier has been a faculty member at Dana-Farber, Boston Children’s Hospital and Harvard Medical School, also in Boston, since 2002, the release said.
She succeeds Scott Armstrong, MD, PhD, who was named senior vice president for drug discovery and chief research strategy officer at Dana-Farber.
Dr. Stegmaier will begin serving in her new roles April 1.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
